ABL Bio and GSK’s Landmark Neurodegenerative Therapy Deal
Partnership focuses on platform that enables drugs to cross the blood-brain barrier without compromising its protective qualities. South Korean biotech … Continue reading "ABL Bio and GSK ink $2.5b neurodegeneration...